Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V) - Halperin, J L; Executive Steering Committee, SPORTIF III and V Study Investigators (Am Heart J, 2003)